Cookies Policy

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

I accept this policy

Find out more here

Alzheimer's disease: from bench to bedside

No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.

Brill’s MyBook program is exclusively available on BrillOnline Books and Journals. Students and scholars affiliated with an institution that has purchased a Brill E-Book on the BrillOnline platform automatically have access to the MyBook option for the title(s) acquired by the Library. Brill MyBook is a print-on-demand paperback copy which is sold at a favorably uniform low price.

This Article is currently unavailable for purchase.
Add to Favorites
You must be logged in to use this functionality

Cover image Placeholder

Alzheimer's disease (AD) is the most common cause of dementia worldwide. It causes major debility for the elderly with medical, social and economic implications. The pathology of AD was described in early twentieth century. Significant scientific progress has been made to date in understanding the pathophysiology and genetics as well as developing therapeutic strategies for slowing disease progression and providing symptomatic relief to AD patients. This chapter reviews these advances and explores the links, molecular genetics and cellular biology has provided us today to tackle this devastating disorder.


Full text loading...


Data & Media loading...

Article metrics loading...



Can't access your account?
  • Key

  • Full access
  • Open Access
  • Partial/No accessInformation